🚨STUDY: Nattokinase DISSOLVES 84% of amyloid microclots within 2 hours in-vitro — a pathology recently found in 100% of COVID-19 vaccinated individuals tested.

🚨STUDY: Nattokinase DISSOLVES 84% of amyloid microclots within 2 hours in-vitro — a pathology recently found in 100% of COVID-19 vaccinated individuals tested.

This natural enzyme breaks down BOTH the trigger (spike protein) AND the pathological result (amyloid microclots). https://t.co/Zdo1OHOCoc pic.twitter.com/VqEYZYWQmH

— Nicolas Hulscher, MPH (@NicHulscher) January 15, 2026

Remember, this is in-vitro, not in vivo. In vivo is Latin for “within the living.” It refers to work that’s performed in a whole, living organism.

NICOLAS HULSCHER: [Nattokinase] breaks down BOTH the trigger (spike protein) AND the pathological result (amyloid microclots).

🚨STUDY: Nattokinase DISSOLVES 84% of amyloid microclots within 2 hours in-vitro — a pathology recently found in 100% of COVID-19 vaccinated individuals tested.

This natural enzyme breaks down BOTH the trigger (spike protein) AND the pathological result (amyloid microclots). https://t.co/Zdo1OHOCoc pic.twitter.com/VqEYZYWQmH

— Nicolas Hulscher, MPH (@NicHulscher) January 15, 2026